Chris Martin CMartin@DavidJamesGroup.com | 630-670-2745
DENVER- The International Association for the Study of Lung Cancer (IASLC) has selected Abuja, Nigeria resident Caleb Egwuenu as a participant for the Supportive Training for Advocates on Research and Science (STARS) Program as a Patient Research Advocate (PRA).
The STARS program aims to help patient advocates evolve into patient research advocates—a distinction explained by a PRA’s ability to bring the patient voice to research-related efforts. PRAs work with clinicians and scientists to provide the patient perspective for lung cancer research and policy.
Egwuenu lost both his cousin and aunt to cancer and was told that the disease they died from was “a white man’s disease.” Between 2007 and 2008, he started searching for the truth and meeting with other patients with cancer. He soon learned that anyone could contract lung cancer, regardless of race, medical history, or age.
Egwuenu started a nonprofit with his friends who were also affected by cancer. With no prior experience, he organized hospital visits, where support and care were given to patients with cancer. He also started awareness seminars and screenings to help educate people that early detection can save lives.
Egwuenu is also a research advocate, trying to promote research on cancer in Nigeria. Caleb and his team are in the process of analyzing data obtained from more than 2,000 women who have been screened by the organization since 2008.
STARS Mentors and PRAs will receive complimentary registration to attend the IASLC 2020 World Conference on Lung Cancer (WCLC), to be held virtually January 28-31 2021. The WCLC is the largest international conference specific to lung cancer. To prepare for WCLC, Mentors and PRAs will participate in communication learning labs through Research Advocacy Network, education sessions and meetings with key opinion leaders in the lung cancer community.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes nearly 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2020.iaslc.org.